Scrotal hemangioma

Summary

Scrotal hemangioma (MONDO:0003951) is a disease. A subtype of skin hemangioma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	scrotal hemangioma
Mondo ID	MONDO:0003951
DOID	DOID:663
NCIT	C6387
UMLS	C1335936
MedGen	235583
Anatomy (UBERON)	UBERON:0001300
Is cancer (heuristic)	no

Also known as: angioma of scrotum · angioma of the scrotum · hemangioma of scrotum · hemangioma of the scrotum · scrotal angioma · scrotal hemangioma · scrotum hemangioma

Disease family

This is a subtype of skin hemangioma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › cardiovascular organ benign neoplasm › benign blood vessel neoplasm › hemangioma › skin hemangioma › scrotal hemangioma

Related subtypes (9): skin epithelioid hemangioma, cherry hemangioma, angiokeratoma, tufted angioma, verrucous hemangioma, Wyburn-Mason syndrome, Cobb syndrome, angioma serpiginosum, eyelid capillary hemangioma

Subtypes (1): angiokeratoma of scrotum

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.